Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 1.38 is 84% below its 5-year average of 8.42, near the low end of its 5-year range (1.38–16.76).
As of the fiscal period ended Tuesday, June 30, 2026. 45.98% below its 12-month average of 2.56.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.38.
CURRENT RATIO
1.38
CURRENT RATIO AVG TTM
2.56
CURRENT RATIO AVG 3Y
5.30
CURRENT RATIO AVG 5Y
8.42
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-45.98%
CURRENT VS 3Y AVG
-73.94%
CURRENT VS 5Y AVG
-83.59%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.40
median of 616 covered companies
CURRENT VS SECTOR MEDIAN
-59.31%
vs the sector median at left
Market Cap
$1.13B
Current Ratio
33.10
TTM Avg
10.19
3Y Avg
10.19
5Y Avg
10.19
Market Cap
$1.13B
Current Ratio
19.73
TTM Avg
13.53
3Y Avg
9.78
5Y Avg
15.63
Market Cap
$1.11B
Current Ratio
2.40
TTM Avg
3.54
3Y Avg
3.31
5Y Avg
3.13
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| GoodRx Holdings, Inc. (GDRX) | $1.16B | 1.38 | 2.56 | 5.30 | 8.42 |
| Kardigan, Inc. (KARD)vs › | $1.15B | 8.72 | 9.20 | 9.20 | 9.20 |
| Nektar Therapeutics (NKTR)vs › | $1.17B | 10.42 | 4.62 | 5.92 | 7.14 |
| Avalyn Pharma Inc. Common Stock (AVLN)vs › | $1.13B | 33.10 | 10.19 | 10.19 | 10.19 |
| Damora Therapeutics, Inc. (DMRA)vs › | $1.13B | 19.73 | 13.53 | 9.78 | 15.63 |
| MannKind Corporation (MNKD)vs › | $1.19B | 1.72 | 2.49 | 3.01 | 2.95 |
| Harrow Health, Inc. (HROW)vs › | $1.11B | 2.24 | 2.14 | 3.36 | 3.91 |
| Amphastar Pharmaceuticals, Inc. (AMPH)vs › | $1.11B | 2.40 | 3.54 | 3.31 | 3.13 |
| Cronos Group Inc. (CRON)vs › | $1.21B | 16.18 | 19.21 | 18.77 | 16.93 |
| Innovage Holding Corp. (INNV)vs › | $1.22B | 1.05 | 1.06 | 1.16 | 1.68 |
Current Ratio
1.38
Quick Ratio
1.38
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 1.38 |
| 2026-03-31 | 1.47 |
| 2025-12-31 | 2.61 |
| 2025-09-30 | 3.11 |
| 2025-06-30 | 4.21 |
| 2025-03-31 | 5.23 |
| 2024-12-31 | 5.32 |
| 2024-09-30 | 5.48 |
| 2024-06-30 | 7.32 |
| 2024-03-31 | 6.29 |
| 2023-12-31 | 7.12 |
| 2023-09-30 | 8.23 |
| 2023-06-30 | 11.14 |
| 2023-03-31 | 13.15 |
| 2022-12-31 | 12.05 |
| 2022-09-30 | 10.34 |
| 2022-06-30 | 11.23 |
| 2022-03-31 | 16.76 |
| 2021-12-31 | 13.42 |
| 2021-09-30 | 14.47 |
| 2021-06-30 | 16.43 |
| 2021-03-31 | 17.82 |
| 2020-12-31 | 18.24 |
| 2020-09-30 | 19.63 |
| 2020-06-30 | 3.34 |
| 2020-03-31 | 0.00 |
| 2019-12-31 | 2.59 |
| 2019-09-30 | 0.00 |
| 2019-06-30 | 0.00 |
| 2019-03-31 | 0.00 |
